BioNote, Inc. (KRX: 377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,720.00
+85.00 (1.83%)
Nov 15, 2024, 9:00 AM KST

BioNote Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
474,050433,228874,096---
Market Cap Growth
-9.82%-50.44%----
Enterprise Value
61,28016,432174,842---
Last Close Price
4645.004056.338198.67---
PE Ratio
5.81-2.51---
PS Ratio
4.994.811.82---
PB Ratio
0.300.280.55---
P/TBV Ratio
0.270.280.55---
P/FCF Ratio
11.04-4.23---
P/OCF Ratio
8.28-3.51---
EV/Sales Ratio
0.640.180.36---
EV/EBITDA Ratio
2.72-0.58---
EV/EBIT Ratio
4.25-0.59---
EV/FCF Ratio
1.43-0.85---
Debt / Equity Ratio
0.000.000.000.000.000.11
Debt / EBITDA Ratio
0.17-0.000.000.001.07
Debt / FCF Ratio
0.09-0.010.000.001.45
Asset Turnover
0.060.050.300.531.28-
Inventory Turnover
1.731.851.931.871.71-
Quick Ratio
24.4139.3514.944.842.800.98
Current Ratio
25.9342.2616.665.423.121.46
Return on Equity (ROE)
5.31%-1.30%21.43%70.80%141.00%-
Return on Assets (ROA)
0.56%-1.76%11.38%25.02%70.87%-
Return on Capital (ROIC)
0.58%-1.86%12.84%30.64%91.58%-
Earnings Yield
17.20%-4.73%35.21%---
FCF Yield
9.06%-1.88%23.66%---
Dividend Yield
4.88%4.93%----
Payout Ratio
25.00%-16.23%7.38%--
Buyback Yield / Dilution
-4.14%-8.29%-0.64%-0.14%-11.08%-
Total Shareholder Return
-4.14%-3.36%-0.64%-0.14%-11.08%-
Source: S&P Capital IQ. Standard template. Financial Sources.